Colin Martin is a patent technical specialist in the firm’s IP Procurement and Portfolio Management practice group. Prior to joining the firm, Colin served as a research assistant at Carnegie Mellon University where he executed the synthesis, purification, and characterization of peptide nucleic acid oligonucleotides and investigated methods of cellular delivery as a potential therapeutic strategy for the treatment of rare genetic diseases.
This is a temporary biography. A complete biography will be available soon.
